ADVFN
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Pfizer Inc

Pfizer Inc (PFE)

24.635
0.025
( 0.10% )

Pfizer Inc (PFE) Quote

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
24.635
( 0.10% )
Bid
-
Ask
-
Volume
26,925,787
24.60 Day's Range 24.96
20.915 52 Week Range 31.54
Market Cap
Previous Close
24.61
Open
24.68
Last Trade
100
@
24.635
Last Trade Time
15:32:50
Financial Volume
$ 666,192,329
VWAP
24.7418
Average Volume (3m)
42,871,793
Shares Outstanding
5,685,365,587
Dividend Yield
6.98%
PE Ratio
17.46
Earnings Per Share (EPS)
1.41
Revenue
63.63B
Net Profit
8.03B

About Pfizer Inc

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
New York, New York, USA
Founded
-
Pfizer Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker PFE. The last closing price for Pfizer was $24.61. Over the last year, Pfizer shares have traded in a share price range of $ 20.915 to $ 31.54.

Pfizer currently has 5,685,365,587 shares outstanding. The market capitalization of Pfizer is $139.92 billion. Pfizer has a price to earnings ratio (PE ratio) of 17.46.

Pfizer (PFE) Options Flow Summary

Overall Flow

Bearish

Net Premium

-2M

Calls / Puts

85.71%

Buys / Sells

160.00%

OTM / ITM

188.89%

Sweeps Ratio

0.00%

PFE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.055-4.1066562864925.6926.0524.533865566125.32556618CS
40.6752.8171953255423.9626.0523.7653947694524.79915452CS
121.8558.1431079894622.7826.0521.974287179323.79637817CS
26-1.465-5.6130268199226.127.2420.9154666339124.57491417CS
52-4.565-15.633561643829.231.5420.9154143926526.02741901CS
156-27.325-52.588529638251.9654.9320.9153330188731.11192216CS
260-10.965-30.800561797835.661.7120.9153282464436.18114459CS

PFE - Frequently Asked Questions (FAQ)

What is the current Pfizer share price?
The current share price of Pfizer is $ 24.635
How many Pfizer shares are in issue?
Pfizer has 5,685,365,587 shares in issue
What is the market cap of Pfizer?
The market capitalisation of Pfizer is USD 139.92B
What is the 1 year trading range for Pfizer share price?
Pfizer has traded in the range of $ 20.915 to $ 31.54 during the past year
What is the PE ratio of Pfizer?
The price to earnings ratio of Pfizer is 17.46
What is the cash to sales ratio of Pfizer?
The cash to sales ratio of Pfizer is 2.2
What is the reporting currency for Pfizer?
Pfizer reports financial results in USD
What is the latest annual turnover for Pfizer?
The latest annual turnover of Pfizer is USD 63.63B
What is the latest annual profit for Pfizer?
The latest annual profit of Pfizer is USD 8.03B
What is the registered address of Pfizer?
The registered address for Pfizer is 235 EAST 42ND STREET, NEW YORK, NEW YORK, 10017
What is the Pfizer website address?
The website address for Pfizer is www.pfizer.com
Which industry sector does Pfizer operate in?
Pfizer operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OPADOfferpad Solutions Inc
$ 2.2282
(30.30%)
370.11k
BKKTBakkt Holdings Inc
$ 21.70
(21.84%)
833.88k
CRCLCircle Internet Group Inc
$ 236.5399
(21.10%)
39.42M
JOBYJoby Aviation Inc
$ 16.355
(17.24%)
70.92M
STGSunlands Technology Group
$ 13.72
(17.06%)
138.47k
SQNSSequans Communications SA
$ 3.88
(-17.80%)
6.5M
ARDTArdent Health Inc
$ 11.9797
(-13.94%)
875.88k
DXYZDestiny Tech100 Inc
$ 33.4001
(-13.49%)
3.91M
ZEPPZepp Health Corporation
$ 12.6886
(-9.37%)
839.89k
HVT.AHaverty Furniture Companies Inc
$ 20.74
(-8.31%)
257
BBAIBigBear ai Holdings Inc
$ 7.21
(1.55%)
116.57M
NUNu Holdings Ltd
$ 13.741
(1.48%)
90.77M
FFord Motor Company
$ 11.295
(-2.38%)
84.85M
JOBYJoby Aviation Inc
$ 16.355
(17.24%)
70.92M
QSQuantumscape Corp
$ 11.1784
(3.03%)
70.62M

PFE Discussion

View Posts
DewDiligence DewDiligence 47 minutes ago
The word, "immediately" in your post is wrong. Pharma tariffs won't start for 12-18 months—if they happen at all.
👍️0
tw0122 tw0122 8 hours ago
...
Eli Lilly (LLY), Merck (MRK), Pfizer (PFE) and other pharmaceutical companies that manufacture drugs abroad are expected to be affected immediately, the news outlet reported. Trump recently said tariffs on pharmaceuticals could reach up to 200%, according to the report.
👍️0
Vexari Vexari 4 days ago
Proof

Is in the pudding
Researchers are blocked from studying unvaccinated children.

They’ve hid the data away under lock and key.

Because they claim it’s “unethical” to study unvaccinated children.
👎️ 1 💊 1 🗑️ 1 🤪 1
Monroe1 Monroe1 5 days ago
https://www.vigilantfox.com/p/what-happens-when-you-compare-vaccinated?publication_id=975571&post_id=168047050&isFreemail=true&r=47wykb&triedRedirect=true

The push for what works has always been an uphill battle since Rockyfella created modern "medicine" with his quacks inserted into the system approval process. Nice to see society pushing back for real health and wellness.
👍️ 1 🗑️ 1
Vexari Vexari 6 days ago
To a skid
30+
🎃 1 💊 1 🕳️ 1 🗑️ 1
Cameo Brien Cameo Brien 6 days ago
30+
👍️ 1 💥 1
DarthYoda DarthYoda 1 week ago
Oh look I found the Scott Gottlieb emoji...🧛
👍️ 1
Monroe1 Monroe1 1 week ago
Survival
😎 1
Monroe1 Monroe1 1 week ago
Karma is a bitch that's for sure.
👍️ 1
Vexari Vexari 2 weeks ago
Deception rampant

These are war crimes

Capital punishment
💯 1 🕳️ 1 🗑️ 1 🚽 1 🤢 1 🤪 1
Vexari Vexari 2 weeks ago
Smog of illusion
🎃 1 👎️ 1 🕳️ 1 🗑️ 1 🤢 1
Vexari Vexari 2 weeks ago
Layman English?
Hympavzi phase-3 succeeds in hemophilia patients with inhibitors, opening the door for an expanded label:

https://finance.yahoo.com/news/pfizer-announces-positive-topline-phase-104500015.html

Hympavzi, which is given by a weekly subcutaneous injection, is a tissue-factor pathway inhibitor (TFPI) that works on the extrinsic pathway of the coagulation cascade (the opposite side of the cascade from FXIII and FIX) and provides a benefit in both hemophila A and B. The FDA approved Hympavzi for hemophilia patients without inhibitors in Oct 2024 (#msg-175217202). Pros and Cons
👎️ 1 💊 1
Vexari Vexari 2 weeks ago
How pharmaeseish

Medical form of legalese
💊 1 🗑️ 1 🚽 1
BottomBounce BottomBounce 2 weeks ago
"BREAKING: Pfizer Busted Using Irrelevant Study to Deny Genome Integration Risks from Their mRNA Injections

Pfizer's bogus claim ignores four independent sources showing mRNA-DNA interaction—cites a completely unrelated paper on SARS-CoV-2 evolution to deny genome alteration risks." BREAKING: Pfizer Busted Using Irrelevant Study to Deny Genome Integration Risks from Their mRNA Injections

Pfizer's bogus claim ignores four independent sources showing mRNA-DNA interaction—cites a completely unrelated paper on SARS-CoV-2 evolution to deny genome alteration… pic.twitter.com/iBwRobFKkZ— Peter A. McCullough, MD, MPH® (@P_McCulloughMD) June 29, 2025 $PFE
👍️ 1 👎️ 1 🕳️ 1 🗑️ 1 🤣 1
Monroe1 Monroe1 3 weeks ago
Dive into this one > https://www.thefocalpoints.com/p/breaking-pfizer-busted-using-irrelevant?publication_id=1119676&post_id=167039061&isFreemail=true&r=x7hm&triedRedirect=true

The public has had enough of their junk science. They knew what they were doing and the FDACDC helped them do it.
Thank God new leadership RFK Jr. is cleaning house. Anyone reading this who had a relative or friend die from their junk science dumped on us?
Well, they committed murder and contemplated it. What should happen? Fanny slap?
👍️ 1 🗑️ 1
DarthYoda DarthYoda 3 weeks ago
"Kennedy says HHS will know cause of 'autism epidemic' by September":
April 11, 2025
https://www.msn.com/en-us/health/other/kennedy-says-hhs-will-know-cause-of-autism-epidemic-by-september/ar-AA1CH5ai
👍️ 1 👎️ 1 🕳️ 1 🗑️ 1 😎 1
DarthYoda DarthYoda 3 weeks ago
"Former FDA Commissioner Scott Gottlieb warns that RFK Jr’s upcoming autism report will link aluminum in vaccines to autism and trigger a legal firestorm."
Jun 26, 2025
He says the claim could open Pandora’s box by unleashing a wave of lawsuits through the Vaccine Injury Compensation Program.
Gottlieb believes the fallout could be severe enough to force vaccine makers out of the market entirely.
Former FDA Commissioner Scott Gottlieb warns that RFK Jr’s upcoming autism report will link aluminum in vaccines to autism and trigger a legal firestorm.

He says the claim could open Pandora’s box by unleashing a wave of lawsuits through the Vaccine Injury Compensation Program.… pic.twitter.com/WduVInTbEK— Shadow of Ezra (@ShadowofEzra) June 27, 2025
👍️ 1
Saving Grace Saving Grace 3 weeks ago
Proposed funding cuts to the National Institutes of Health might not make a huge splash in biopharma right away, but industry leaders have expressed concern over potential ripples left in their wake.

As they stand currently, cuts by the Trump administration would lower the NIH budget in 2026 by about 40% to less than $28 billion, consolidating the agency while putting ongoing and future grants in jeopardy. Considering almost every new drug approved between 2010 and 2019 stemmed in some way from NIH funded research, experts have warned that the pace of U.S. innovation could be deeply affected by these measures.

While the proposed budget faces a fight from lawmakers and judges to keep grants flowing, leaders in pharma and biotech are worried about the effect even a diminished reduction would have on scientific progress.

“If you don’t plant the seeds, you’re not going to have any wheat,” said Kevin Noonan, partner at biopharma intellectual property law firm MBHB. “There are plenty of industries that do their own R&D, but for the past 40 years, this is one where more of the innovation flows from universities.”

A loss of future scientific discovery is only part of the picture. Cuts of the magnitude proposed by the administration could also threaten the U.S.’s position as a leader in medical advancement, a biopharma pipeline that has come to depend on NIH innovation to move forward and the trajectory of early science careers, leaders said.
Brain drain

The cuts would bring the NIH budget to about where it was in 2006 when President George W. Bush slashed funding for the first time since 1970, according to an MIT Technology Review article at the time. And innovation in the field has become increasingly complicated in the years since.

The industry’s aims have shifted to disease targets with a much higher bar for entry, Noonan pointed out. Rather than a scattershot approach to find pharma’s low-hanging fruit, scientists now need to explore underlying biology and be more intentional in their discovery process to remain on the cutting edge.

“If you don’t plant the seeds, you’re not going to have any wheat."

Kevin Noonan

Partner, MBHB









👍️ 1
DewDiligence DewDiligence 3 weeks ago
Hympavzi phase-3 succeeds in hemophilia patients with inhibitors, opening the door for an expanded label:

https://finance.yahoo.com/news/pfizer-announces-positive-topline-phase-104500015.html

Hympavzi, which is given by a weekly subcutaneous injection, is a tissue-factor pathway inhibitor (TFPI) that works on the extrinsic pathway of the coagulation cascade (the opposite side of the cascade from FXIII and FIX) and provides a benefit in both hemophila A and B. The FDA approved Hympavzi for hemophilia patients without inhibitors in Oct 2024 (#msg-175217202).
👍️ 1
Monroe1 Monroe1 3 weeks ago
Nice to see the ass kicking boot on the right people finally.
Pussies being shoved out. Not a dry eye in the pig house. https://www.fiercepharma.com/pharma/fdas-acting-cder-head-corrigan-curay-heads-exit-amid-period-heavy-turnover-reports?oly_enc_id=4924G0643390I0A

Pfuzzy fizzer just can't get no respect anymore. Maybe that karma stuff is real after all.
👍️ 1
Vexari Vexari 4 weeks ago
Those controlled by fear

Become easy targets

Without resistance
👍️ 1 👎️ 1 🕳️ 1 🗑️ 1 🚽 1
Monroe1 Monroe1 4 weeks ago
How true. Here is our weekend viewing;
https://www.vigilantfox.com/p/exclusive-darpas-shocking-bioterror?publication_id=975571&post_id=166374254&r=x7hm&triedRedirect=true

Trust? Whatever happened to that...."trust your doctor" .... bygone era.
👍️ 1 🗑️ 1 🤣 1
Vexari Vexari 4 weeks ago
Just think of that $$$$$$$$$$$$$$$$
💊 1 🕳️ 1 🗑️ 1 😎 1 🚯 1 🚽 1
Vexari Vexari 4 weeks ago
What is it about reality

That makes one think
👎️ 1 💊 1 🕳️ 1 🗑️ 1
BottomBounce BottomBounce 1 month ago
https://x.com/DiedSuddenly_/status/1933721666086973590/photo/1 $PFE
👍️ 1 👎️ 1 🗑️ 1 🤢 1 🤪 1 🥱 1
Monroe1 Monroe1 1 month ago
Opps, now Pig Pharma will know what it feels like to be on the losing end.
https://www.thegatewaypundit.com/2025/06/rfk-jr-appoints-several-prominent-critics-covid-19/
👍️0
Monroe1 Monroe1 1 month ago
very good video explanation. deniers please do your DD and get back to us here with your rebuttal and evidence.
Thank you so much.
👍️ 1 🕳️ 1 🗑️ 1 🚽 1
Monroe1 Monroe1 1 month ago
Breaking: RFK Jr. Removes All Members of CDC Vaccine Advisory Committee

HHS Secretary Robert F. Kennedy Jr. announced late today that he is retiring all 17 members of the CDC vaccine advisory committee. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy wrote in an op-ed published today in The Wall Street Journal.
by Brenda Baletti, Ph.D.Suzanne Burdick, Ph.D.
June 9, 2025
👍️ 1
Monroe1 Monroe1 1 month ago
I hope so and in a new honest direction.
👍️0
biotech_researcher biotech_researcher 1 month ago
$25 next.. The narrative from Mr. Market is, we are moving on....
👍️0
biotech_researcher biotech_researcher 1 month ago
Pfizer's dividend over three years provide you $5.16. Just think of that..
👍️ 2
BottomBounce BottomBounce 1 month ago
Bill Gates just admitted that the Pfizer and Moderna mRNA vaccines don’t work well. pic.twitter.com/6GQ3DQk8aN— Ezra Levant 🍁🚛 (@ezralevant) November 9, 2021 $PFE
🗑️ 2 🤥 1
Vexari Vexari 1 month ago
Sums it up in a meme

https://needtoknow.news/wp-content/uploads/2024/10/Patient-cured-is-a-customer-lost.jpg
👎️ 2 🕳️ 1 🗑️ 2 🤪 1
Vexari Vexari 1 month ago
The disturbing truth

About FDA, CDC and Big Pharma

A learning experience
👍️ 1 👎️ 1 🕳️ 1 🗑️ 1 🚽 2
axelvento axelvento 1 month ago
$MRNA long live the pussy
🎩 1 🙌 1
Vexari Vexari 1 month ago
What causes breast cancer

What is breast cancer

Why treat

When it can be prevented

Or cured
👎️ 1 💊 1 🗑️ 1 🤪 1 🧻 1
biotech_researcher biotech_researcher 2 months ago
https://investors.pfizer.com/Investors/News/news-details/2025/Pfizers-BRAFTOVI-Combination-Regimen-Cuts-the-Risk-of-Death-in-Half-for-Patients-with-BRAF-V600E-Mutant-Metastatic-Colorectal-Cancer/default.aspx
👍️ 2
axelvento axelvento 2 months ago
Pfizer and Arvinas gamble to shift breast cancer treatment paradigm


The full trial results are to be announced on 31 May at the 2025 American Society of Clinical Oncology conference.
👍️ 1 💯 2 😄 2
biotech_researcher biotech_researcher 2 months ago
Moving on:US drops COVID vaccine recommendations for healthy children, pregnant women - https://www.reuters.com/business/healthcare-pharmaceuticals/us-drops-covid-vaccine-recommendations-healthy-children-pregnant-women-2025-05-27/
👍️0
BottomBounce BottomBounce 2 months ago
I got it. I do wish I hadn’t. Had a blip on my EKG that was either vaccine related or covid. It corrected itself. I got two shots of Moderna and what I do think it caused is papular urticaria that I cannot get rid of. It’s subsided almost entirely from when it first came up but…— Michelle (@BFL_Michelle) May 22, 2025 $PFE
👎️ 1 🗑️ 1
biotech_researcher biotech_researcher 2 months ago
https://www.worldpharmaceuticals.net/news/astellas-pfizers-xtandi-shows-long-term-benefits-in-prostate-cancer/
👍️ 1
Vexari Vexari 2 months ago
Why is the FDA so tone deaf

Beholden to big pharma
👎️ 1 🗑️ 1 🤢 1 🤪 1
Vexari Vexari 2 months ago
Who did the lie benefit the most

Myths and misconceptions of salt
👎️ 1 🕳️ 1 🗑️ 1 🤪 1 🫵 1
Monroe1 Monroe1 2 months ago
Subpar results. Old FDA would rubber stamp this.... those days are long over.
👍️0
Vexari Vexari 2 months ago
What is cancer?
🗑️ 1 🫵 1
biotech_researcher biotech_researcher 2 months ago
Pfizer Inc. (NYSE:https://finance.yahoo.com/quote/PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust five-year survival results for XTANDI (enzalutamide) combined with androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer. Data from the Phase 3 ARCHES trial show XTANDI plus ADT cuts the risk of death by 30%, with a 66% five-year survival rate versus 53% for ADT alone. XTANDI is now the first androgen receptor inhibitor to demonstrate such a long-term survival benefit, reinforcing its position as a standard of care for this patient group.
https://finance.yahoo.com/news/pfizer-inc-pfe-delivers-oncology-145939821.html
👍️ 1 💥 1 💯 1
Vexari Vexari 2 months ago
Stepping out of the shadows

Risking everything

Careers, reputations, even life itself

To expose

What may be the largest crime against humanity in modern history
👍️ 1 👎️ 2 💊 1 🗑️ 1 🤥 1 🤪 1
Vexari Vexari 2 months ago
Truth is consistent
👍️ 1 💊 1 💤 1 😵‍💫 1 🤢 1
Monroe1 Monroe1 2 months ago
Phuzzy PFE just can't get a break. Well maybe once in the cell culture....behind bars, they will have plenty of time to reflect on their diabolical manners. Opps, you crapped in your own mess kit.
https://www.globalresearch.ca/covid-vaccine-safe-effective-narrative-collapses-camera/5887991
🗑️ 2 🤪 1
Monroe1 Monroe1 2 months ago
Genocide and further more.... Edward Dowd, a financier focused on analyzing excess deaths data, has warned of a potential global demographic crisis if these findings hold true for humans. His comments have drawn attention to the need for further investigation into the vaccines’ effects on fertility. The study’s implications have sparked discussions among experts and policymakers alike.

The persistence of the spike protein, as observed in another study, has also raised safety concerns. Researchers have found that the protein can remain in the body for an extended period, prompting calls for more research. These findings have added to the growing list of questions about the long-term effects of COVID vaccines.

https://news.spreely.com/jim-jordan-investigates-pfizer-covid-vaccine-trials-amid-concerns-about-potential-impact-on-fertility/

Diving deeper we find the excavator way past asshole deep and decreasing the likelihood of ever climbing out. The company may well face being shut down.
👍️ 1 😵‍💫 1

Your Recent History

Delayed Upgrade Clock